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Correction: Discovery and validation of a
prognostic proteomic signature for
tuberculosis progression: A prospective
cohort study
Adam Penn-Nicholson, Thomas Hraha, Ethan G. Thompson, David Sterling, Stanley
Kimbung Mbandi, Kirsten M. Wall, Michelle Fisher, Sara Suliman, Smitha Shankar, Willem
A. Hanekom, Nebojsa Janjic, Mark Hatherill, Stefan H. E. Kaufmann, Jayne Sutherland,
Gerhard Walzl, Mary Ann De Groote, Urs Ochsner, Daniel E. Zak, Thomas J. Scriba, ACS
and GC6–74 cohort study groups
In supplemental file S4 Fig, the labels for “controls” and “progressors” were switched. The cor-
rected S4 Fig can be found here.
Supporting information
S4 Fig. Distribution of signature scores for the TRM5 and 3PR in the combined ACS train-
ing and test cohorts and the GC6–74 validation cohort. Mann–Whitney test P values are
shown for comparison of each signature on different progressor and nonprogressor samples
run on the different SOMAscan assays. 3PR, 3-protein pair-ratio; ACS, Adolescent Cohort
Study; GC6–74, Grand Challenges 6–74; SOMAscan; TRM5, TB Risk Model 5.
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